loading
Precedente Chiudi:
$1.63
Aprire:
$1.7
Volume 24 ore:
29,398
Relative Volume:
0.59
Capitalizzazione di mercato:
$29.46M
Reddito:
-
Utile/perdita netta:
$-21.91M
Rapporto P/E:
-1.1208
EPS:
-1.49
Flusso di cassa netto:
-
1 W Prestazione:
-4.57%
1M Prestazione:
-21.23%
6M Prestazione:
-12.57%
1 anno Prestazione:
-51.45%
Intervallo 1D:
Value
$1.64
$1.70
Intervallo di 1 settimana:
Value
$1.60
$1.75
Portata 52W:
Value
$1.50
$8.4697

Incannex Healthcare Inc Stock (IXHL) Company Profile

Name
Nome
Incannex Healthcare Inc
Name
Telefono
61 409 840 786
Name
Indirizzo
401 DOCKLANDS DRIVE, DOCKLANDS, VICTORIA
Name
Dipendente
9
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
IXHL's Discussions on Twitter

Confronta IXHL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
IXHL
Incannex Healthcare Inc
1.67 29.46M 0 -21.91M 0 -1.49
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
170.90 77.10B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.47 42.82B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.39 42.45B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.73 20.09B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
151.82 15.37B 2.24B 385.90M 440.10M 3.73

Incannex Healthcare Inc Borsa (IXHL) Ultime notizie

pulisher
Jan 27, 2025

Incannex Healthcare Announces Positive Topline Results from PK Study - Defense World

Jan 27, 2025
pulisher
Jan 23, 2025

Incannex Reports Positive Data for OSA Drug Candidate IHL-42X - Sleep Review

Jan 23, 2025
pulisher
Jan 23, 2025

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea - The Manila Times

Jan 23, 2025
pulisher
Jan 23, 2025

Incannex Reports Strong Results for Sleep Apnea Drug IHL-42X in Key Clinical Study - StockTitan

Jan 23, 2025
pulisher
Jan 13, 2025

Incannex Healthcare faces Nasdaq delisting over market value By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 13, 2025

Incannex Healthcare faces Nasdaq delisting over market value - Investing.com

Jan 13, 2025
pulisher
Jan 13, 2025

Reviewing Alterity Therapeutics (NASDAQ:ATHE) and Incannex Healthcare (NASDAQ:IXHL) - Defense World

Jan 13, 2025
pulisher
Jan 12, 2025

IXHLIncannex Healthcare Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Jan 12, 2025
pulisher
Jan 11, 2025

Incannex Healthcare Inc. Receives Notice of Listing Deficiency from NasdaqOn January 3, 2025, Incannex Healthcare Inc. (NASDAQ: IXHL) received a written notice from The Nasdaq Stock Market LLC stating that the company is not in compliance with Nasda - Defense World

Jan 11, 2025
pulisher
Jan 11, 2025

U.S. Energy (NASDAQ:USEG) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World

Jan 11, 2025
pulisher
Jan 08, 2025

Financial Security Advisor Inc. Has $12.95 Million Position in Microsoft Co. (NASDAQ:MSFT) - Defense World

Jan 08, 2025
pulisher
Dec 12, 2024

Incannex Healthcare secures shareholder approvals at annual meeting By Investing.com - Investing.com Canada

Dec 12, 2024
pulisher
Dec 12, 2024

Incannex Healthcare secures shareholder approvals at annual meeting - Investing.com

Dec 12, 2024
pulisher
Dec 03, 2024

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025 - Nanton News

Dec 03, 2024
pulisher
Dec 02, 2024

Incannex Completes Key FDA Trial Phase, Advances Anxiety Drug Development | IXHL Stock News - StockTitan

Dec 02, 2024
pulisher
Dec 02, 2024

Incannex Healthcare (IXHL) & Its Rivals Critical Review - Defense World

Dec 02, 2024
pulisher
Nov 23, 2024

Incannex Healthcare Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024
pulisher
Nov 19, 2024

Incannex Healthcare (NASDAQ:IXHL) Shares Up 5.5% – Still a Buy? - Defense World

Nov 19, 2024
pulisher
Nov 19, 2024

Incannex Healthcare (NASDAQ:IXHL) Trading Up 5.5%What's Next? - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Incannex Healthcare Reports Q3 Loss, Secures New Funding - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Incannex Healthcare Inc (IXHL) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Incannex Secures $59M Financing, Reports Q1 Results Amid Clinical Trial Progress | IXHL Stock News - StockTitan

Nov 14, 2024
pulisher
Oct 25, 2024

Incannex Healthcare names Lou Barbato as chief medical officer - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Incannex appoints new chief medical officer - Investing.com India

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex appoints new chief medical officer By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex Healthcare Appoints Dr. Barbato as CMO - TipRanks

Oct 24, 2024
pulisher
Oct 22, 2024

Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks - Simply Wall St

Oct 22, 2024
pulisher
Oct 22, 2024

Incannex Healthcare secures $3.3 million through debt financing By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

Incannex Healthcare secures $3.3 million through debt financing - Investing.com

Oct 21, 2024
pulisher
Oct 17, 2024

Incannex Healthcare secures A$6.9 million funding By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 15, 2024

Incannex Healthcare secures A$6.9 million funding - Investing.com

Oct 15, 2024
pulisher
Oct 03, 2024

Incannex Provides Business Updates and Progress on OSA Drug Candidate in Phase 2/3 Trials - Sleep Review

Oct 03, 2024
pulisher
Oct 02, 2024

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL) - Invezz

Oct 02, 2024
pulisher
Oct 01, 2024

R&D tax breaks buoy Incannex as losses narrow - Green Market Report

Oct 01, 2024
pulisher
Sep 30, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short Interest - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - The Manila Times

Sep 30, 2024
pulisher
Sep 13, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat

Sep 13, 2024
pulisher
Sep 11, 2024

Incannex Secures Up to $60M in Financing to Support Clinical Trials - Sleep Review

Sep 11, 2024
pulisher
Sep 10, 2024

Incannex secures financing deal valued at US$60 million - Mugglehead

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex $60 Million Deal With Arena For Late-Stage Drug TrialsIncannex Healthcare (NASDAQ:IXHL) - Benzinga

Sep 10, 2024

Incannex Healthcare Inc Azioni (IXHL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$31.53
price down icon 1.19%
$12.03
price down icon 3.53%
$92.51
price down icon 0.30%
$11.28
price down icon 1.23%
$127.08
price up icon 0.06%
$151.82
price down icon 0.96%
Capitalizzazione:     |  Volume (24 ore):